ClinicalTrials.Veeva

Menu

Surgeon Experience ReSTOR A +4 Intraocular Lens (IOL)

Alcon logo

Alcon

Status

Completed

Conditions

Cataract

Treatments

Device: ReSTOR

Study type

Observational

Funder types

Industry

Identifiers

NCT00733512
M07-019

Details and patient eligibility

About

To collect visual outcome data post AcrySof ReSTOR Aspheric +4 implantation from surgeons throughout the United States.

Enrollment

146 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • operable cataracts; candidate for presbyopic correcting intraocular lens (IOL)

Exclusion criteria

  • ocular comorbidities confounding study outcomes

Trial design

146 participants in 1 patient group

ReSTOR
Description:
AcrySof ReSTOR Aspheric +4 Intraocular Lens (IOL)
Treatment:
Device: ReSTOR

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems